Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 3,781-3,792 of 4,306
Other study type icon
CompletedNCT00696813

Observational Study to Assess Outcomes During Antipsychotic Treatment With Paliperidone ER or Other Oral Antipsychotics

This study is completed in Canada, in Czechia, in Denmark, .... It focuses on Schizophrenia.

Multiple locations, including Victoria
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
Canada, Czechia, Denmark, ...
Sponsor
Janssen-Cilag International NV
Condition
Schizophrenia
Drug study icon
TerminatedNCT00748566

One-Year study Of Oral Ziprasidone In people with Metabolic Syndrome

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Calgary
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
Canada
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT01432444

Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole

This study is completed in the United States and in Canada. It focuses on Schizophrenia.

Multiple locations, including Dothan
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Canada
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
TerminatedNCT01454453

Optimisation of Antipsychotic Drug Use in Older People

This summary needs review. Please check the official study record and contact the research team for details.

In London
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 60 Years to 95 Years
Countries
United Kingdom
Sponsor
Institute of Psychiatry, London
Condition
Schizophrenia
Drug study icon
CompletedNCT02087579

Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Garden Grove
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, Depression, ...DrugFrom 18 Years to 70 Years
Countries
United States, Belgium, Argentina, ...
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia, Depression, ...
Other study type icon
CompletedNCT01575912

Past Pain Experience and Perception of Experimental Pain

This summary needs review. Please check the official study record and contact the research team for details.

In Limoges
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, DepressionObservationalFrom 18 Years to 60 Years
Countries
France
Sponsor
Centre Hospitalier Esquirol
Condition
Schizophrenia, Depression
Behavioral study icon
CompletedNCT03527914

Patient Generated Goals in Mental Health: Better Outcomes?

This summary needs review. Please check the official study record and contact the research team for details.

In Ottawa
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 4 Years to 18 Years
Countries
Canada
Sponsor
Children's Hospital of Eastern Ontario
Condition
Schizophrenia
Behavioral study icon
CompletedNCT01133587

Patient Guided Psychiatric Admissions

This summary needs review. Please check the official study record and contact the research team for details.

In Trondheim
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityBehavioralOver 18 Years
Countries
Norway
Sponsor
St. Olavs Hospital
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT01914393

Pediatric Extension Study

This study is completed in the United States, in France, in Bulgaria, .... It focuses on Schizophrenia.

Multiple locations, including Dothan
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, Bipolarity, ...DrugFrom 6 Years to 17 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia, Bipolarity, ...
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.